Gil Addo is CEO and Co-Founder of RubiconMD, a wholly-owned subsidiary of Oak Street Health. RubiconMD’s digital health platform empowers primary care clinicians with access to virtual specialty care from top medical specialists to improve patient care. Founded in 2013, RubiconMD serves primary care clinicians across 37 states. The Huffington Post named RubiconMD one of the “Five Companies Defining the Future of Healthcare” and, in 2020, AllianceBernstein ranked RubiconMD number 12 on its list of the top 25 private companies disrupting healthcare. Prior to founding RubiconMD, Gil was a Consultant at Putnam Associates, a pharma strategy consultancy, where he designed payer and market access strategies for Fortune 500 clients. He previously held strategy and business development roles at Xerox, Cubist (acquired by Merck), and two early-stage healthcare ventures. Gil has appeared in Inc., Forbes, CNBC, Fortune, and Entrepreneur Magazine. He’s been named one of Forbes’ “30 Under 30” in healthcare, Crains New York’s Business 40 Under 40, and Business Insider’s 30 under 40 in healthcare. In 2020, Crains New York named Gil to its list of the Most Notable in Health Care and in 2017, he received their Heritage Healthcare Innovator of the Year award. He holds a BS in Economics and Biomedical Engineering from Yale and an MBA from Harvard.

Payal is a Partner at .406 Ventures, where she co-leads the digital health investing practice. .406 Ventures is a Boston-based venture capital firm with ~$1B under management. The firm invests in enterprise-oriented start-ups in sectors including digital health, cybersecurity, and data & cloud. Payal’s portfolio includes AristaMD, Better Life Partners, Diana Health, Equip, Heartbeat Health, Nomad Health, Redox, Wayspring, WelbeHealth, Wellist, and Virtudent. Previously, Payal co-founded a company called SpotRocket to help students discover high-potential start-ups to work for. Payal has also worked at Eventbrite, Spectrum Equity, and J.P. Morgan. Payal received her MBA, with Distinction, from Harvard Business School and her BS in Electrical Engineering and minor in Management from MIT. She is a Boston native and she and her husband, who is a physician at Brigham and Women’s Hospital, and two kids live in Brookline.

Ali is a founding team member and leads all clinical matters for Summer Health, a pediatric health tech company revolutionizing access to care for children and families. Prior to Summer Health, Ali was a clinical strategy executive at Humana. He also worked at Boston Consulting Group where he led projects across biopharma, med tech, payors, and federal government. Ali is also on staff as a hospitalist at Boston Children's Hospital, where he completed his pediatric training. He received his bachelor's from MIT and medical degree from Harvard Medical School. He also holds a Master's of Science in health policy from the London School of Economics, where he was a Marshall Scholar.

Anuradhika is the System Vice President of Strategic Partnerships at CommonSpirit Health and focuses her time on Strategic Investment Fund and other Innovation efforts. She is passionate about leveraging innovation & investments for the triple aim of reducing cost, improving quality, and increasing access to health care. She is a multi-faceted leader with a diverse background in strategy, operations, and health care startups, with 16+ years of experience in leading partnerships, catalyzing revenue growth, and scaling innovative solutions and business functions from ground up. Anuradhika holds a Masters degree in Healthcare Administration from the University of Washington, Seattle. She is also a trained pharmacist from Rajiv Gandhi University of Health Sciences, India, and is a certified Lean leader. In her free time, Anuradhika is keen to support inclusion and women empowerment and has held board positions with organizations dedicated to these causes.

Christopher Booker is a partner with Frist Cressey Ventures (FCV), a Nashville-based healthcare venture firm. He joined FCV in 2016, and is responsible for acquisition, divestitures, and providing unique value to the fund’s partnerships as a member of the fund’s Investment Committee. Mr. Booker has served on the board of directors of numerous healthcare companies. He is a current director of FCV’s portfolio companies Monogram Health, Seven Springs Orthopaedics, ObjectiveGI, and 180 Health Partners. In addition to his responsibilities at FCV, he is a member of the Board of Directors for WhoUWith Ministries, Woodland Street Partners, and Vanderbilt University Entrepreneurship Advisory Council, and founder & co-chair of the HITRUST Venture Program. Prior to joining FCV, Mr. Booker was a partner at XMi Holdings, Inc., managing its investment funds, and President of XMi Capital. While at XMi Holdings, he was Chief Financial Officer and served as a director to healthcare services firm Criterion Holdings Corporation, Inc. Mr. Booker graduated from Vanderbilt University with a BS in Engineering and Economics. He resides in Nashville, Tennessee, with his wife, Katherine, and children, Ella, Jackson, and Griffin.

Ian is a Partner at Flare Capital, led the firm’s investment into Knownwell and was an essential part of the firm’s investments in Inbound Health and RightMove, where he serves as a board member, as well as Cayaba Care, and Oshi Health. Additionally, Ian led the firm’s Flare Scholar Ventures investments in Adni, EarlyBird Education, Narrable, and Vincere Health. Prior to joining Flare Capital, Ian served as a Senior Vice President and a founding member of CareAllies, Cigna’s family of multi-payer provider services, population health management, and home-based care businesses. In that capacity, he was responsible for developing new technology-enabled services, evolving existing solutions and service lines, and providing ongoing product management across CareAllies’ businesses. In addition, he was also responsible for developing inorganic strategies for CareAllies since its inception. Before launching CareAllies, Ian held a leadership position with Cigna’s US Strategic Operations team. Ian was a co-founder of several start-ups, including XcelDx, which ultimately partnered with Scanwell Health, a smartphone-enabled diagnostics company backed by Y-Combinator, Founders Fund, DCM, Version One, and Mayfield. He focused his efforts on product development and served as an advisor to the company. Scanwell was acquired by BD (Becton, Dickinson and Company) in 2021. He also worked for Becton, Dickinson & Company, where he led new product innovation and development. He continues to actively advise and mentor a number of innovative healthcare start-ups. He started his career at McKinsey & Company and spent five years advising healthcare clients globally. Ian serves as an advisor and board member of various organizations. He is currently a member of the Board of Directors at The New England Venture Capital Association and Harvard Business School Healthcare Alumni Association, where he also served as the 2021 Annual Conference Co-Chair. Additionally, Ian serves as an Industry Advisor at Cornell Tech’s The Precision Behavioral Health Initiative. Ian has a Bachelor of Science degree in biological engineering from Cornell University, where he graduated with honors and was a Cornell Presidential Research Scholar. He also holds an MBA from Harvard Business School.

Chris Coburn is CIO, Mass General Brigham (formally Partners HealthCare System). Mass General Brigham consists of Harvard University affiliates Brigham and Women’s Hospital, Massachusetts General Hospital, Massachusetts Eye and Ear, and McLean Hospital. Mass General Brigham is the nation’s largest academic research enterprise with over $13 billion in annual revenue, 1.5 million patient visits, and $2.4 billion in research expenditures. It also has a managed-care organization, outpatient facilities, and community hospitals. Mass General Brigham's 3700 faculty are appointed at Harvard Medical School. Mr. Coburn leads a team of more than 125 tasked with the worldwide commercial application of the unique capabilities and discoveries of all Mass General Brigham's 74,000 employees. His unit’s business development responsibilities include investing, company creation, innovation management, industry collaborations, and licensing. Commercialization revenue exceeds $130 million annually and more than 225 companies have been spun-off from Mass General Brigham in the last decade. Largescale industry collaborations have been established in areas such as AI and drug development. Provider strategy and operational consulting have been delivered to clients in nearly 40 countries. His group also manages a nearly $200 million venture fund. Prior to joining Mass General Brigham, Mr. Coburn was founding director of Cleveland Clinic Innovations and served for 13 years as its executive leader. During his tenure Cleveland Clinic spun off 57 companies that raised more than $700 million in equity financing. There were none before Coburn’s arrival. His team also managed an innovation alliance network in which Cleveland Clinic directly supported technology commercialization for healthcare systems throughout the United States. Mr. Coburn has been a member of numerous corporate and community boards including Explorys (acquired by IBM), Autonomic Technologies, and the U.S. Enrichment Corporation (NYSE:USU).

Julie Betts Ebert is a Managing Director on the National Life Science & Healthcare team at Silicon Valley Bank, covering the Mid-Atlantic and Southeast markets. Julie provides specialized banking services and debt-financing solutions, as well as advice on strategic growth, to healthcare companies across all life stages, from early-stage venture-backed enterprises to late-stage public companies. Before joining the commercial banking team, Julie spent several years leading SVB’s Strategic Advisory effort, where she was responsible for managing client engagements and leading execution for advisory projects. Prior to joining SVB, Julie worked for 10 years at Greenhill & Co. LLC, a boutique investment bank, spending time in both their New York and London offices. While at Greenhill, Julie advised both public and private companies on M&A and restructuring transactions. She managed both buy-side and sell-side processes, completed complex corporate valuations, conducted transaction negotiations, and provided strategic advice. Julie has broad experience across a range of sectors, with a focus on healthcare. Before Greenhill, Julie also worked at Prudential Securities in the M&A Group and at J.P. Morgan in the Syndicated Leveraged Finance Group. Julie received an M.B.A. with honors from Columbia Business School and a B.S. from the McIntire School of Commerce at the University of Virginia with concentration in finance.

Brenton leads AlleyCorp’s healthcare investments and incubations as managing partner of AlleyCorp Healthcare. Prior to AlleyCorp, Brenton was an executive at Flatiron Health. He worked previously at J.P. Morgan and Blue Cross & Blue Shield. Board-certified in Internal Medicine, Brenton previously practiced at Memorial Sloan Kettering and completed residency at Brigham and Women’s Hospital. He graduated summa cum laude from the University of Pennsylvania, earning an MD from the University of Pennsylvania School of Medicine and an MBA in Healthcare Management from the Wharton School.

Katerina leads venture investment activity and portfolio management for Philips Ventures in North America, the strategic venture arm of Philips. She is based in Boston, MA, and is focused on health technology investment opportunities that align with Philips’ strategy to improve people's health and well-being through meaningful innovation. She is a board director or board observer at several startups including MOVN Health, PreciseDx, Babyscripts, Orbita, and Carevive. Katerina has 20+ year global experience in finance, M&A, and venture capital in technology and digital health sectors, holds an MBA from MIT, and is an ACCA-certified chartered accountant. She is also a founding partner at OKM Capital and mentor and judge at MassChallenge startup accelerator. Organizing committee member for the MIT Sloan CFO Summit. Member CFO Leadership Council. Member Financial Executives International (FEI). Ambassador for the AI Innovators Community.

Keith J. Figlioli joined LRVHealth in 2016, as a General Partner after nearly two decades of experience building and growing healthcare IT and services companies. Before joining LRVHealth, Keith was Senior Vice President of Healthcare Informatics at Premier, Inc. (NASDAQ: PINC) where he led the company’s enterprise healthcare technology business unit and helped the company raise $820M in its IPO. Prior to Premier, Keith was Senior Vice President of Enterprise Solutions at Eclipsys (acquired by Allscripts NASDAQ: MDRX). He is a board member of IntelyCare, Upfront Healthcare, Season Health, Censinet, and Reimagine Care, and a board observer for Diana Health, Genome Medical, and Xealth. He previously served on the Board of Trustees at Wheaton College, the Strategy Committee of Baystate Health, the Health IT Standards Committee for the Office of the National Coordinator (ONC), and the board of directors for Global Healthcare Exchange (GHX), Activate Networks, Good Sports, and MassBike. Keith earned his B.A. from Wheaton College, M.B.A. from Boston University, and M.P.H. from Harvard T.H. Chan School of Public Health.

Josh Flum joined LRVHealth in 2022 as a Managing Partner after nearly two decades of experience driving growth and innovation at CVS Health. Before joining LRV, Josh served as Executive Vice President, Chief Strategy & Business Development Officer at CVS Health where he was responsible for assessing dynamic market forces and driving organizational responses in a rapidly evolving healthcare and consumer landscape. In this role, Josh led a broad set of transformational activities ranging from the integration of CVS Health and Aetna to the founding of CVS Health Ventures, a venture capital fund that advances CVS Health’s strategy through investment and partnership with innovative digital health companies. Josh earned his bachelor’s degree from Tufts University and is a graduate of the Yale Law School.

Robert A. Gabbay, MD, PhD, is Chief Scientific and Medical Officer of the American Diabetes Association and Associate Professor at Harvard Medical School. His research focuses on innovative models of diabetes care to improve diabetes outcomes and the lives of people with diabetes. Throughout his vibrant career he has had many accomplishments as a basic science researcher, developer of patient communication tools, creator of the first broad scale diabetes registry, designer of care management training programs, and leader of one of the largest primary care transformation efforts in the US around the Patient Centered Medical Home. The reach of his work has been recognized through leadership roles around the world to transform diabetes care including leading the International Diabetes Federation BRIDGES program that implements evidence-based translational research to low-resource global settings. Dr. Gabbay has received funding from the National Institute of Health Diabetes, Digestive and Kidneys Diseases (NIDDK), the Agency for Healthcare Research and Quality (AHRQ), and the Center for Medicare and Medicaid Innovation for his care transformation work. Along with an extensive peer reviewed publication record, his views have appeared in popular press such as the New York Times, CNN, the Washington Post, People, Oprah, and National Public Radio. Formerly, he held the role of Chief Medical Officer at Joslin Diabetes Center.

As the Co-Founder and CEO of Oshi Health, Sam is combining his passion for redesigning healthcare around the needs of patients with a mission to increase access to the high quality, whole-person care that two of his family members have needed to manage their digestive conditions. Sam is leading Oshi’s growth and democratizing access to high value digestive care that’s proven to achieve unmatched clinical outcomes, member engagement, satisfaction, and cost savings. Working at the intersection of payment innovation and care transformation, he is accelerating systemic change in specialty care. He has achieved national-scale specialty value-based care contracts with commercially insured plans that serve as a model for how to pay for outcomes that both matter to patients and drive significant cost savings. Having invested in creating robust evidence, Sam is aligning all healthcare stakeholders to bring this critically needed care to millions of people: payers provide covered in-network access to Oshi for their members; employers promote Oshi to improve the health and presenteeism of their workforce; provider groups partner with Oshi to extend their practices; and patients come to understand their condition and triggers for sustainable control over their symptoms. Under his leadership, Oshi has built a specialized clinical workforce and empowered culture that thrives in delivering true relationship-based care, earning Oshi multiple ‘Best Places to Work’ honors. He has held leadership roles across healthcare technology and tech-enabled services companies focused on improving population health. These include scaling a tech-enabled diabetes management company, a data-driven health system patient acquisition platform, and population health tools for a leading electronic medical record (EMR) company. Sam lives in New York City with his family and enjoys comparing notes with other innovators in healthcare, deepening his knowledge of how our bodies and brains work, and cheering on Philadelphia sports teams and NYCFC.

Ryan Howells is a nationally recognized digital health policy and interoperability expert based out of the Leavitt Partners Washington, D.C., office, who regularly works with the White House, Congress, HHS, and the VHA. Since 2016, Ryan has led the CARIN Alliance, which has advanced consumer-directed exchange using FHIR APIs. CARIN’s work has been implemented in production across the U.S., named as an “industry best practice” in multiple federal regulations, and received a World Changing Idea Award by Fast Company magazine. Ryan also works with CMS and NCQA to advance digital quality measures, the Utah Governor’s office on their statewide FHIR interoperability pilot, and with CDC and ONC on public health data modernization. Ryan is a previous General Manager of a digital health product company and current board member for multiple health care companies. He also serves on the CMS MITA Governance Board, Carequality Steering Committee and the ONC’s FAST Identity Tiger Team. Ryan has a MHA from USC and a BA from BYU. He lives in Athens, GA, with his wife Alison and 5 children.

Dr. Brigham Hyde is CEO and co-founder of Atropos Health since August 2022. He provided funding and support for Atropos Health’s official launch in late 2020. Hyde has a significant track record of building businesses in the health tech and real-world data (RWD) space and most recently served as President of Data & Analytics at Eversana. Prior to that role, Mr. Hyde served as a healthcare partner at the AI venture fund Symphony AI, where he led the investment in, co-founded, and operated Concert AI, an oncology RWD company - most recently valued at $1.9B. Hyde held previous roles as Chief Data Officer at Decision Resources Group, which was acquired by Clarivate for $900M in 2020. He has also served on the Global Data Science Advisory Board for Janssen, as a research faculty at MIT Media Lab, and served as adjunct faculty at Tufts Medical School.

Alyssa Jaffee is a Partner at 7wireVentures where she invests in companies that empower everyone to be better stewards of their health. Her portfolio includes Caraway Health, Ayogo Health, MedArrive, Brightline, Zerigo Health, NOCD, and Jasper Health. Previously, Alyssa was an investor at Pritzker Group Venture Capital and Hyde Park Angels. Alyssa is also a cofounder of TransparentCareer, a NVC winning company helping people make more data-driven career decisions. Alyssa spent time at the Advisory Board Company where she launched new technologies and consulted hundreds of hospital executives to understand their needs and recommend solutions. Alyssa attended the University of Wisconsin-Madison and received an MBA from the University of Chicago’s Booth School of Business. Her work and accomplishments have been featured in Fortune, Stat News, MedCity News, Crain’s, and more.

Nandini is a seasoned professional who seamlessly transitioned from a successful career as a pharmaceutical scientist to becoming a conference and business networking expert with over 16 years of experience within the biopharmaceutical industry and the partnering ecosystem. As the Senior Director of Conferences and Social Media Strategy at Cambridge Healthtech Institute, she and her team play a pivotal role in fostering connections among key stakeholders in the biotech, MedTech, and digital health sectors. She holds a bachelor's in pharmacy and a master's in pharmacy in Pharmaceutics and is a published author and speaker in diabetes and insulin delivery space. Beyond her professional endeavors, she is a fitness enthusiast who passionately advocates for fitness and postpartum weight loss. She is an Indian American Pageant winner, and enjoys dancing, modeling, and being the human spinner in response to endless requests of "Mommy, spin me!".

Michael is co-founder and CEO of Pearl Health. Michael served as an early employee and Vice President at Oscar Health, where he built their sales and network functions. He managed the company’s largest P&L at +$2.5B before helping take the company public with its IPO. Prior to Oscar, Michael worked for Bridgewater Associates in the company’s Research, Client Service, and Recruiting departments. While at Bridgewater, he was the Head of Research Analytics where he reported to the CEO and Ray Dalio. In 2009, he successfully sold DormAid, a college service company, which he launched and ran while he was a student at Harvard. He is the recipient of Columbia’s Feldberg Fellowship, where he received his M.B.A. He received his A.B. from Harvard College. In 2024, he was selected as a Presidential Leadership Scholar.

Andrea Linna is a partner at Wilson Sonsini Goodrich & Rosati, where she is part of the firm’s digital health industry group and its healthcare practice. During the last 10 years, Andrea has focused her practice on healthcare law and amassed substantial experience representing clients in healthcare regulatory matters related to digital health and healthcare IT. Her clients include healthcare technology start-ups and industry investors, as well as healthcare systems, providers, payers, and facilities with digital health initiatives. Prior to joining the firm, Andrea was a partner at McGuireWoods in Chicago and served as co-leader of its digital health, technology and innovation practice. Before that, she was a partner at Honigman LLP. Andrea frequently speaks and writes about emerging healthcare and technology topics. She has been quoted by CNBC and Crain’s and has given guest lectures on healthcare law at Northwestern University's Feinberg School of Medicine and Pritzker School of Law, the University of Michigan School of Public Health, Loyola University School of Law, and The Wharton School of the University of Pennsylvania. Andrea is practicing virtually in Chicago. She is licensed in Illinois, Michigan, and Ohio.

Samir is currently the CEO of Firsthand, a value-based care business delivering engagement and better outcomes for those struggling with serious mental illness. Most recently served as the CEO of Genoa Telepsychiatry, and an EVP at Optum. Samir and his partners founded 1DocWay in 2011 with a mission of increasing access to behavioral healthcare for the underserved. Over the course of 10 years, Samir and his team led 1DocWay through incubation, venture financing, an exit /PE recap in 2015 and then another exit to Optum in 2018 as the largest provider of telepsychiatry services in the nation, currently serving over 250k+ Medicaid appointments per year. Prior to 1DocWay, Samir served as the President of Signature Healthcare and Director at CenterPointe Hospital, midwest-based behavioral health inpatient and outpatient providers, before selling the combined businesses to private equity firms, where he still serves on the Board of Directors. Samir started his career as a consultant for McKinsey focused on payors and providers.

Tarun Mehra is Vice President of Healthcare Strategy, M&A, and Partnerships at Microsoft / Nuance. His role is focused on advancing the overarching Nuance + Microsoft Healthcare strategy across Provider and Payor segments. Prior to his current role, Tarun spent about 18 years in various strategy consulting roles serving large corporate and private equity clients in healthcare and technology sectors. Most recently, Tarun was an Associate Partner with Monitor Group (now Deloitte) advising large IDNs and health plans on growth strategy, portfolio assessment, M&A due diligence, and innovation strategy. Prior to that, he led the healthcare consulting business at Fuld & Co. and also founded a new line of business for the firm, which he ran as CEO for two years before helping find a strategic exit. He began his career in technology and product development and later transitioned to business strategy roles post his MBA. Tarun completed mechanical engineering from Indian Institute of Technology (IIT), Delhi, and received his MBA from Indian Institute of Management (IIM), Indore.

Physician executive with a passion for improving healthcare, specializing in risk-based primary care, MSO, population health management, physician alignment and engagement, health plan innovation and design, pharmacy benefit management, healthcare informatics, and building innovative businesses. Strong background in academic medicine, government service at CMS and ONC, and leading a start-up Managed Services Organization for 10,000 Medicare Advantage members from concept to a successful business. Effective communication skills to Board of Directors, investors, senior management team, management with team-oriented approach to organizational success. High aptitude for solving complex strategic problems and creating successful solutions to achieve operational excellence.

Farzad Mostashari, MD ScM is the CEO of Aledade - the largest network of independent primary care practices in the country. Since founding Aledade in 2014, he has helped the company grow to serve more than 1,500 practices in 45 states, be accountable for the care of more than two million patients, and prevent more than $1 billion in unnecessary health care costs. Dr. Mostashari currently serves on the Founder's Council of United States of Care, is a Visiting Fellow at the Duke-Margolis Center for Health Policy at Duke University, serves as co-chair of the Health Evolution Summit and is on the board of directors for Resolve to Save Lives - a global health organization that aims to save millions of lives from cardiovascular disease and infectious disease epidemics. Dr. Mostashari is the former National Coordinator for Health IT at the Department of Health and Human Services, and served as a distinguished expert at the Brookings Institute’s Engelberg Center for HealthCare Reform. Prior to his work at the Office of the National Coordinator, he founded the NYC Primary Care Information Project. Dr. Mostashari received his MD from Yale University School of Medicine and his Masters in Population Health from Harvard T.H. Chan School of Public Health.

Alexi Gharib Nazem, MD, MBA, is the co-founder and CEO of Nomad Health, the first online marketplace for freelance clinical jobs. In addition to leading Nomad, he is also a Clinical Assistant Professor of Medicine at Weill Cornell in New York. Previously, he led field operations for the Institute for Healthcare Improvement’s successful 100,000 Lives Campaign. Alexi trained in internal medicine at Brigham & Women’s Hospital in Boston after receiving an MD from Yale and an MBA from Harvard. He also holds a BS in Molecular Biophysics and Biochemistry from Yale.

Lynne joined Surescripts as the company’s first Chief Data and Analytics Officer in August, 2023. As a physician, Lynne has always been interested in helping people live healthier, happier lives. She brings nearly 30 years of healthcare experience to Surescripts, including over 10 years leading data science, product, and business analytics teams. After earning an undergraduate degree from the University of Notre Dame and an MD from the University of Illinois, she began her clinical career with a residency at the Mayo Clinic. She spent 15 years practicing as a board-certified internal medicine physician, which included founding an inpatient hospitalist practice and serving as medical director of a nonprofit hospice. Before joining Surescripts, Lynne served as CMO at Lark Health, where she oversaw business insights, analytics engineering, and clinical research and strategy. Prior to Lark Health, Lynne served as Vice President/General Manager of Clinical Data and Provider Solutions at Cigna/Evernorth/Express Scripts. Lynne actively supports military veterans in her community, serving on the Greater St. Louis Honor Flight Board of Directors. She has also been involved in numerous efforts mentoring and encouraging girls and women in STEM and mentoring emerging business leaders in healthcare. Lynne can often be found in her garden, at the lake, or venturing to the beach or mountains with her family and friends. She currently lives in Belleville, IL, with her husband and has two daughters.

Tom leads all aspects of the investment process from deal sourcing through board management and is responsible for identifying, investing in and partnering with entrepreneurs that are unlocking new growth possibilities in health care to further accelerate Cigna’s mission. He brings over twenty years of digital health experience, including roles as digital health venture partner at Safeguard Scientifics and Managing Director of Innovation and Strategic Investing at Independence Blue Cross. He earned a bachelor’s degree from Princeton University. Tom lives in Pennsylvania with his wife, and enjoys travel, fly fishing, and other outdoor activities.

Kevin is the co-founder of Health Tech Nerds, the leading community of health care innovators. HTN helps innovators across the industry to learn about the evolving healthcare landscape and connect with other like-minded individuals. Prior to starting HTN, Kevin held a variety of leadership roles in the industry. Most recently he led innovation for Allina Health. Prior to that, Kevin helped launch Harken Health, a UHC-backed ACA insurance plan, and he also founded a digital therapeutic startup.

David Reshef is a computer scientist, physician, and venture partner at GV, where he focuses on investing at the intersection of machine learning, healthcare, and life sciences. David’s career has focused on using machine learning to identify and characterize structures in high-dimensional data. His work has been published in high-impact journals, including Science, Proceedings of the National Academy of Sciences, The Journal of Machine Learning Research, and The Annals of Applied Statistics. He has focused on applications across a broad range of fields, including computer-aided diagnostics, disease modeling, high-throughput screens, and immunotherapy. David completed training in internal medicine at Brigham and Women's Hospital. He holds an MD with honors from Harvard Medical School and a PhD in computer science from MIT, where he was a Soros Fellow and a National Science Foundation Fellow. Before that, he studied statistics at the University of Oxford as a Marshall Scholar and computer science at MIT. His work was awarded a best thesis award from the Department of Electrical Engineering and Computer Science at MIT.

Russ Richmond, MD is a physician entrepreneur with experience building digital health companies such as Laudio, Advanced Practice Strategies, Objective Health, Verisk Health, and D2Hawkeye, as well as counseling large payors and health systems while at McKinsey & Company. Russ is currently the co-founder and CEO of Laudio, a digital health company founded in 2018 to empower frontline leaders in healthcare, and, in turn, help health systems enhance operational efficiency, employee engagement, and patient care. Russ also serves on the Mass General Brigham AI Fund investment committee. He completed his internship in Internal Medicine and Pediatrics at the University of Michigan, and earned his MD from the University of Cincinnati and a BS in Biology from the University of Michigan. He lives in Newton, MA with his wife and three children.

Ben Robbins is a General Partner at Google Ventures (GV), investing across healthcare delivery and neuropsychiatric therapeutics. As a psychiatrist by background, Ben also leads GV’s investments in mental health-related companies, including Headway and Brightline. His investments include Aspire (acquired by Anthem), Rodin (acquired by Alkermes), Carebridge, Patina, Waltz Health, Nym, and Cerevance. Ben joined GV as a venture partner in 2014 and was named general partner in 2022. In a past life, Ben worked as an intern at “The Daily Show” with Jon Stewart. Since then, he has completed psychiatric training at Massachusetts General Hospital and Mclean Hospital, the top and second-ranked departments of psychiatry in the United States. He also co-founded a non-profit to fund, build, and operate a primary school for AIDS orphans in Tanzania. Ben received his M.D. from Harvard Medical School, MBA from Harvard Business School, and B.A. with honors from Dartmouth College, where he was a member of the football team.

Darshak Sanghavi, MD, is one of the first program managers of a newly created multibillion dollar federal agency, the Advanced Research Projects Agency for Health, or ARPA-H. With access to the resources of the National Institutes of Health, ARPA-H reports directly to the U.S. Secretary of Health and Human Services, and has been given the ambitious goal of “accelerating better health outcomes for everybody by supporting the development of high-impact solutions to society’s most challenging health problems.” Specifically, Darshak will be leading efforts around public health projects aimed at entirely new methods of investing in technology and strategies to improve public health. Previously, Darshak was Global Chief Medical Officer for Babylon, the global end-to-end digital health care provider serving over a dozen countries and over 24 million people, with the mission of bringing "affordable and accessible health care to everyone on Earth." He was a member of the senior leadership team taking the company public in 2021, and currently oversees the company’s global operations. He is the former Chief Medical Officer of UnitedHealthcare's Medicare & Retirement, the largest U.S. commercial Medicare program with over $90B in annual revenue, where he directed all major national clinical and affordability programs. Earlier, he was Chief Medical Officer at OptumLabs, the R&D hub of UnitedHealth Group, running a large portfolio of industry-leading projects with dozens of academic, government, and industry partners. Before then, he was a member of the Obama administration, as the Director of Preventive and Population Health at the Center for Medicare and Medicaid Innovation, where he directed the development of large pilot programs aimed at improving the nation’s health care costs and quality. In this capacity, he was the architect of numerous initiatives, including the $157 million Accountable Health Communities model, the 3 million member Million Hearts Cardiovascular Risk Reduction model, and the $1 billion Medicare Diabetes Prevention Program. Dr. Sanghavi was also a fellow and a managing director of the Brookings Institution, and associate professor of pediatrics and the chief of pediatric cardiology at UMass Medical School (where he still sees patients). He is an award-winning medical educator, who has worked in medical settings around the world and published dozens of scientific papers on topics ranging from the molecular biology of cell death to tuberculosis transmission patterns in Peruvian slums. A frequent guest on NBC's Today and past commentator for NPR's All Things Considered, Dr. Sanghavi is a contributing editor to Parents magazine, a health care columnist with Slate, and has regularly written about health care for the New York Times, Boston Globe, and Washington Post. His best-seller, A Map of the Child: A Pediatrician's Tour of the Body, was named a best health book of the year by the Wall Street Journal. He previously worked as a U.S. Indian Health Service pediatrician on a Navajo reservation. Educated at Harvard and Johns Hopkins, he completed his pediatrics residency and cardiology fellowship at Harvard Medical School and Children's Hospital Boston.

Suchi Saria, PhD is an AI Professor at Johns Hopkins where she holds the John C. Malone endowed chair and is the Director of AI and health lab. She is also the founder and CEO of Bayesian Health, a clinical AI platform company that augments care teams by bringing together state of the AI/ML technology combined with responsible AI best practices to dramatically improve quality while saving clinicians' time. Dr. Saria’s work in AI over the last two decades has led to foundational advances in the technology, best practices around translation, and AI policy. She has written several seminal papers in AI/ML around issues of learning robust models, detecting drifts, monitoring and learning from messy real-world datasets. Her applied research has built on these technical advances to develop novel next generation diagnostic and treatment planning tools that use AI/ML to individualize care. Her work has been funded by leading organizations including the NSF, DARPA, FDA, NIH and CDC and she regularly serves as a scientific advisor to leading Fortune 500 companies. Dr. Saria completed her PhD in AI at Stanford, her BSc in Physics, Computer Science and Statistics at Mount Holyoke. She’s a Sloan Research Fellow, named by IEEE to “AI’s 10 to Watch”. Modern Healthcare’s Top 25 Innovators, World Technology Forum’ Technology Pioneer, and her work was recognized as one of TIME’s Best Inventions in 2023. She is on the board of the Coalition of Health AI (CHAI), editorial board of the Journal of Machine Learning Research and serves on the National Academy of Medicine AI Code of Conduct.

Deena's investments span stages and sectors and include women's health, digital health infrastructure, health equity, foodtech, and fintech. Above all, she seeks out extraordinary -- often underdog -- founders on a mission. Prior to Lux, Deena was a Partner at GV (formerly Google Ventures), led product partnerships at Google for health, search, and AI/ML, and directed social impact investments at Google.org. Deena also served as a Presidential Management Fellow at The U.S. Department of State under Secretary Clinton, where she helped launch President Obama’s first Global Entrepreneurship Summit. Deena self-funded her undergraduate degree at Harvard (Social Studies and Near Eastern Languages & Civilizations) and MA at Georgetown through a variety of merit scholarships and side hustles, including co-founding and selling her first company while in college. She is a Lecturer in Management at the Stanford Graduate School of Business, a Board Director for the National Venture Capital Association, and a member of Kauffman Fellows, Aspen Finance Fellows, and The Council on Foreign Relations. Deena is a frequent speaker and commentator and has been featured in print and television on Bloomberg, CNBC and NBC, in print in the Wall Street Journal, Fortune, Forbes, Techcrunch, Marie Claire, STAT, and more, and has delivered keynote addresses at major industry conferences. She was named a "Top 30 Under 40 in Healthcare" by Business Insider and "Top Senior Woman to Watch in Venture Capital" by the Wall Street Journal in 2021, "Top 50 in Digital Health" by Rock Health, and 40 Under 40 by Fortune Magazine in 2022.

Micky Tripathi is the National Coordinator for Health Information Technology at the U.S. Department of Health and Human Services, where he leads the formulation of the federal health IT strategy and coordinates federal health IT policies, standards, programs, and investments. Dr. Tripathi has over 20 years of experience across the health IT landscape. He most recently served as Chief Alliance Officer for Arcadia, a health care data and software company focused on population health management and value-based care, the project manager of the Argonaut Project, an industry collaboration to accelerate the adoption of FHIR, and a board member of HL7, the Sequoia Project, the CommonWell Health Alliance, and the CARIN Alliance. Dr. Tripathi served as the President and Chief Executive Officer of the Massachusetts eHealth Collaborative (MAeHC), a non-profit health IT advisory and clinical data analytics company. He was also the founding President and CEO of the Indiana Health Information Exchange, a statewide HIE partnered with the Regenstrief Institute, an Executive Advisor to investment firm LRVHealth, and a Fellow at the Berkman-Klein Center for Internet and Society at Harvard University. He holds a PhD in political science from the Massachusetts Institute of Technology, a Master of Public Policy from Harvard University, and an AB in political science from Vassar College. Prior to receiving his PhD, he was a Presidential Management Fellow and a senior operations research analyst in the Office of the Secretary of Defense in Washington, DC, for which he received the Secretary of Defense Meritorious Civilian Service Medal.

Megann Vaughn Watters is an experienced corporate development executive and investor with over 10 years of novel technology identification, partnership development, deal execution, alliance management, financial and strategic return, and venture-backed board experience within the healthcare industry. As the Vice President of New Ventures & Strategic Alliances at Labcorp, Megann manages the Labcorp Venture Fund and leads the Corporate Development team tasked to identify, assess, and bring innovative science and technology to Labcorp through partnerships, such as equity investments, licensing, commercial collaborations. Megann previously held positions at the United States Patent and Trademark Office as a Patent Examiner for medical devices and Humacyte conducting tissue engineering research. Megann received her M.B.A. from the Duke University Fuqua School of Business and her B.S.E. in Biomedical Engineering from Duke University Pratt School of Engineering.

Elisa has 20+ years of experience building and leading strategic human resources, people, and talent functions in rapidly growing and evolving organizations. Her passion and expertise lie in inspiring diverse, people-first cultures and strong, ecosystem-minded teams that drive organizational impact and performance. She has a a BA and an Ed.M from Boston University, has been an adjunct faculty member at Bentley University, a certified coach, a TEDx speaker, and served on several non-profit Boards.

No bio available.

Carrie Williams brings 20 years of experience in healthcare from several vantage points within the industry. Prior to joining McKesson Ventures in 2017, Williams served as vice president of strategy and business development for digital health provider Omada Health, having held roles within McKesson’s strategy and business development team previously, working to advance strategies aimed at innovation within hospital pharmacy and clinical trial patient recruitment. She began her career in drug development, where she managed oncology clinical trials in both large pharmaceutical and biotech settings. Williams holds an MBA from the Haas School of Business at the University of California at Berkeley and an undergraduate degree in biology from the University of Massachusetts Amherst.